CIK 0001641281 · <br>Emerging growth company
Bolt Biotherapeutics, Inc.
Sign in to watch- Ticker
- BOLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472804636
- Phone
- 650-665-9295
- Business address
- 900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Bolt Therapeutics, Inc.
- Open-market buys, last 90 days
- $319,000
- in 1 filing
- Open-market sales, last 90 days
- $128,281
- in 3 filings
Net +$190,719. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-12 | O'CALLAGHAN BRIAN Director | Grant or award · Director Stock Option (Right to Buy) | +1,100 | 1,100 | ||
| 2025-12-12 | O'CALLAGHAN BRIAN Director | Returned to the company · Director Stock Option (Right to Buy) | −1,100 | 0 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Grant or award · Employee Stock Option (Right to Buy) | +1,236 | 1,236 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Returned to the company · Employee Stock Option (Right to Buy) | −1,236 | 0 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Grant or award · Employee Stock Option (Right to Buy) | +375 | 375 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Returned to the company · Employee Stock Option (Right to Buy) | −375 | 0 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Grant or award · Employee Stock Option (Right to Buy) | +600 | 600 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Returned to the company · Employee Stock Option (Right to Buy) | −600 | 0 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Grant or award · Employee Stock Option (Right to Buy) | +2,199 | 2,199 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Returned to the company · Employee Stock Option (Right to Buy) | −2,199 | 0 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Grant or award · Employee Stock Option (Right to Buy) | +6,699 | 6,699 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Returned to the company · Employee Stock Option (Right to Buy) | −6,699 | 0 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Grant or award · Employee Stock Option (Right to Buy) | +1,589 | 1,589 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Returned to the company · Employee Stock Option (Right to Buy) | −1,589 | 0 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Grant or award · Employee Stock Option (Right to Buy) | +2,499 | 2,499 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Returned to the company · Employee Stock Option (Right to Buy) | −2,499 | 0 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Grant or award · Employee Stock Option (Right to Buy) | +4,499 | 4,499 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Returned to the company · Employee Stock Option (Right to Buy) | −4,499 | 0 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Grant or award · Employee Stock Option (Right to Buy) | +11,299 | 11,299 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Returned to the company · Employee Stock Option (Right to Buy) | −11,299 | 0 |
Page 5 of 17 · 337 trades